Conectus
From the laboratory to the market
launching innovations for a better world!

Since 2012, SATT Conectus has been detecting inventions that originate in Alsace's public research laboratories and investing financially in their technological development. Our objective: to transfer these innovative technologies to companies in order to industrialize them and launch them on the market.

The innovative technologies supported by Conectus

Developing a new therapy against cancer, countering antibiotic resistance, making a window "smart", developing a new waterproofing treatment, imagining a new detector for pollutants in ambient air, treating the adverse effects of chemotherapies... Each year, some fifteen innovative projects led by Alsatian researchers benefit from a financial investment from Conectus (up to €500k / project) to gain in maturity and become innovative products or services accessible to all on the market.

 

In which areas does Conectus invest in innovative projects?

Health(1)

Medical technologies

Chemicals / Materials

Santé

49%

Robot

11%

Chimie

17%

Engineering(2)

Energy / ecotechnologies

ICT(3)

Innovation

12%

Soleil

8%

Cloud computing

4%

(1) Therapeutics and diagnosis
(2) Robotics, mechanics, electronics....
(3) Digital, IT....

Results are in!

113

innovative projects supported by Conectus since 2012

36,4 M€

invested by Conectus in innovative projects since 2012

320 k€

invested on average per innovative project (year 2017)

103

technology transfers since 2012

154

jobs created since 2012 to develop these innovative projects

40 %

of innovative projects are developed in co-conception

+ 10M€

of revenues from cumulative technology transfers since 2012

167

active intellectual property titles managed 

100 %

innovative projects that have benefited companies established in France
(of which 40% are SMEs)

Do you really want to remove this technology from your list ?
close